锌指蛋白转录因子KLFs家族与心血管疾病
被引量:4
摘要
心血管疾病(cardiovasculardisease)是一系列与心脏血管相关的循环系统疾病。循环系统是指人体内运送血液的器官和组织,主要包括心脏和血管(动脉、静脉、微血管)。心血管疾病以血管病变为主要病理特征,其主要诱因包括炎症反应、内皮细胞损伤、脂代谢异常、血栓和动脉粥样硬化等。在诸多心血管疾病中,危害性最大患病人数最多的有心肌肥大、动脉粥样硬化、糖尿病、冠心病及肥胖等。
出处
《中南医学科学杂志》
CAS
2013年第4期325-331,共7页
Medical Science Journal of Central South China
基金
国家自然科学基金(81273512)
参考文献52
-
1De Boer OJ,Vander Wal AC, Becker AE. Atherosclerosis, inflammation, and infection [ J ]. J Pathol,2000,190 ( 3 ) : 237 -243.
-
2Atkins GB, Wang YM, Mahabeleshwar GH, et al. Hemizy- gous deficiency of Krtippel-like factor 2 augments experi- mental atherosclerosis [ J ]. Cir Res, 2008, 103 (7) : 690-693.
-
3SenBanerjee S, Lin Z, Atkins GB, et al. KLF2 is a novel transcriptional regulator of endothelial proinflammatory ac- tivation [ J]. J Exp Med,2004,199(10) :1305-1315.
-
4Dekker R J, van Soest S, Fontijn RD, et al. Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Krtippel-like factor (KLF2) [ J ]. Blood, 2002,100 ( 5 ) : 1689-1698.
-
5Kumar A, Lin Z, SenBanerjee S, et al. Tumor necrosis fac- tor alpha-mediated reduction of KLF2 is due to inhibition of MEF2 by NF-kappaB and histone deacetylases [ J ]. Mol Cell Biol, 2005,25 (14) :5893-5903.
-
6Atkins GB, Jain MK. Role of Krtippel-like transcription factors in endothelial biology [ J]. Cire Res, 2007, 100 (12) : 1686-1695.
-
7Parmar KM, Larman HB, Dai G, et al. Integration of flow- dependent endothelial phenotypes by Krtippel-like factor 2 [ J ]. J Clin Invest, 2006,116 ( 1 ) :49-58.
-
8Dekker R J, Boon RA, Rondaij MG, et al. KLF2 provokes a gene expression pattern that establishes functional quies- cent differentiation of the endothelium [ J ]. Blood, 2006, 107( 11 ) :4354-4363.
-
9Lin Z, Kumar A, SenBanerjee S, et al. Kriippel-like factor 2 (KLF2) regulates endothelial thrombotic function [ J ]. Circ Res, 2005,96 ( 5 ) : 48-57.
-
10Bhattacharya R, Senbanerjee S, Lin Z, et al. Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kriippel-like factor KLF2 [J]. J Biol Chem,2005,280(32):28848-28851.
同被引文献32
-
1de CatesAN, FarrMR, WrightN, et al. Fixed-dose combination therapy for the prevention of cardiovascular disease[J]. Cochrane Database Syst Rev, 2014, 4:CD009868.
-
2LiX, RenY, SorokinV, et al. Quantitative profiling of the rat heart myoblast secretome reveals differential responses to hypoxia and re-oxygenation stress[J]. J Proteomics, 2014, 98:138–149.
-
3ShimokawaharaH, JougasakiM, SetoguchiM, et al. Relationship between vascular endothelial growth factor and left ventricular dimension in patients with acute myocardial infarction[J]. J Cardiol, 2014, 64(5):360–365.
-
4FriehsI, MargossianRE, MoranAM, et al. Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis[J]. Basic Res Cardiol, 2006, 101(3):204–213.
-
5FischS, GrayS, HeymansS, et al. Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy[J]. Proc Natl Acad Sci U S A, 2007, 104(17):7074–7079.
-
6KaramanolisG, DelladetsimaI, KoulouliasV, et al. Increased expression of VEGF and CD31 in postradiation rectal tissue:implications for radiation proctitis[J]. Mediators Inflamm, 2013, 2013:515048.
-
7SchramK, GangulyR, NoEK, et al. Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeletal reorganization and leads to enhanced cell migration[J]. Endocrinology, 2011, 152(5):2037–2047.
-
8CorreiaC, GraysonWL, ParkM, et al. In vitro model of vascularized bone: synergizing vascular development and osteogenesis[J]. PLoS One, 2011, 6(12):e28352.
-
9JiangY, WangH, CulpD, et al. Targeting Müller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity[J]. Invest Ophthalmol Vis Sci, 2014, 55(2):824–831.
-
10LaroumanieF, Douin-EchinardV, PozzoJ, et al. CD4+ T cells promote the transition from hypertrophy to heart failure during chronic pressure overload[J]. Circulation, 2014, 129(21):2111–2124.
引证文献4
-
1徐丽新,吴志伟,陈华.Kruppel样因子15在心血管系统作用的研究进展[J].世界最新医学信息文摘,2020(50):36-37.
-
2余杨,邹书帆,马杰,陈林.kruppel样因子15在压力超负荷所致心肌重构血管生成中的作用及机制[J].中华心血管病杂志,2015,43(2):162-166. 被引量:4
-
3余杨,邹书帆,马杰,陈林.KLF15基因对压力超负荷所致心肌纤维化的调控作用[J].中华胸心血管外科杂志,2015,31(7):415-418. 被引量:1
-
4何旭,薛艳,王学宗,曹月龙,郑昱新,丁道芳.Klf4抑制Wnt/β-catenin信号通路调控软骨细胞增殖的研究[J].现代中西医结合杂志,2019,28(34):3773-3776.
二级引证文献5
-
1周心涛,赵黎丙,闵新文,陈娇,郎明健.结缔组织生长因子介导动脉粥样硬化易损斑块的形成及机制研究[J].中西医结合心脑血管病杂志,2016,14(19):2281-2284. 被引量:1
-
2李秀,韩科强,石亚男,门素珍,李舒,孙孟华,董浩,卢景晶,马丽娟,赵敏,李丹,刘巍.熊去氧胆酸对异丙肾上腺素诱导的小鼠心肌纤维化的作用[J].中华医学杂志,2017,97(5):387-391. 被引量:6
-
3才让卓玛,陈秀英,连心龙,李佳,张亚萍.原发性高血压合并慢性心力衰竭患者心脏结构改变及危险因素分析[J].疑难病杂志,2017,16(9):865-868. 被引量:14
-
4梁宇明,何燕.心脏压力超负荷状态下内源性心脏保护作用机制研究进展[J].山东医药,2018,58(40):88-90. 被引量:2
-
5杜胜利,范一帆,钟久昌,王乐丰.Kruppel样因子15在冠状动脉粥样硬化性心脏病中的作用[J].国际心血管病杂志,2020,47(5):276-280.
-
1易丽娴,汤新逸,王胜军.KLF4的生物学功能及其研究进展[J].江苏大学学报(医学版),2014,24(6):545-548. 被引量:6
-
2王丹阳,朱广瑾,徐成丽.NF-κB在某些心血管疾病中的作用[J].基础医学与临床,2011,31(9):1070-1073. 被引量:8
-
3小池弘美,陈锡慰.循环系统疾病的基因学[J].日本医学介绍,2001,22(5):207-212.
-
4李军,王纯莹.K^+,Ca^(2+)通道在低氧性肺动脉高压中的作用[J].高原医学杂志,2009,19(2):61-63. 被引量:1
-
5常影,姜新.辛伐他汀在对2型糖尿病大鼠血脂的影响[J].航空航天医药,2010,21(11):1952-1953.
-
6朱小玉,钟雪云,陈运贤.血管内皮生长因子与心脏血管的新生[J].血栓与止血学,2005,11(6):276-278. 被引量:3
-
7李晓玲,刘晓华.间充质干细胞向内皮细胞分化的可塑性及应用研究[J].中华风湿病学杂志,2008,12(4):279-281.
-
8伍树芝.游离脂肪酸升高相关因素分析[J].中国医药指南,2006,4(6):68-69. 被引量:5
-
9林沁,江晓娟,刘利利.大鼠腹膜组织增龄性衰老的分子病理学改变[J].第二军医大学学报,2016,37(4):458-464.
-
10李华婷,贾伟平,包玉倩.翼螺旋转录因子o1和a2与肝胰岛素抵抗的分子机制[J].上海医学,2008,31(11):825-827. 被引量:1